Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ann Degroote

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Microbiology|January 10, 2008
Preclinical testing of new drugs for tuberculosis: current challengesAnne J Lenaerts, Mary Ann Degroote, Ian M Orme
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patientsEdward M Gardner, William J Burman, Mary Ann DeGroote, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary deliveryMercedes Gonzalez-Juarrero, Lisa K Woolhiser, Elizabeth Brooks, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 29, 2011
Torticollis in mice intravenously infected with Mycobacterium tuberculosisElizabeth R Magden, Cristina M Weiner, Janet C Gilliland, et al.
Current Treatment Options in Infectious Diseases|May 23, 2017
Treatment of Non-Tuberculous Mycobacterial Lung DiseaseJulie V Philley, Mary Ann DeGroote, Jennifer R Honda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2012
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosisKelly E Dooley, Carole D Mitnick, Mary Ann DeGroote, et al.
Tuberculosis (Edinburgh, Scotland)|September 4, 2012
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisScott G Franzblau, Mary Ann DeGroote, Sang Hyun Cho, et al.
Genome Announcements|May 30, 2015
Draft Genome Sequence of Mycobacterium chelonae Type Strain ATCC 35752Nabeeh A Hasan, Rebecca M Davidson, Vinicius Calado Nogueira de Moura, et al.
International Journal of Systematic and Evolutionary Microbiology|August 16, 2017
Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samplesRebecca M Davidson, Mary Ann DeGroote, Jamie L Marola, et al.
The Journal of Clinical Investigation|August 2, 2011
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionMaurizio Renna, Catherine Schaffner, Karen Brown, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Microbiology|January 10, 2008
Preclinical testing of new drugs for tuberculosis: current challengesAnne J Lenaerts, Mary Ann Degroote, Ian M Orme
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patientsEdward M Gardner, William J Burman, Mary Ann DeGroote, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary deliveryMercedes Gonzalez-Juarrero, Lisa K Woolhiser, Elizabeth Brooks, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 29, 2011
Torticollis in mice intravenously infected with Mycobacterium tuberculosisElizabeth R Magden, Cristina M Weiner, Janet C Gilliland, et al.
Current Treatment Options in Infectious Diseases|May 23, 2017
Treatment of Non-Tuberculous Mycobacterial Lung DiseaseJulie V Philley, Mary Ann DeGroote, Jennifer R Honda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2012
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosisKelly E Dooley, Carole D Mitnick, Mary Ann DeGroote, et al.
Tuberculosis (Edinburgh, Scotland)|September 4, 2012
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisScott G Franzblau, Mary Ann DeGroote, Sang Hyun Cho, et al.
Genome Announcements|May 30, 2015
Draft Genome Sequence of Mycobacterium chelonae Type Strain ATCC 35752Nabeeh A Hasan, Rebecca M Davidson, Vinicius Calado Nogueira de Moura, et al.
International Journal of Systematic and Evolutionary Microbiology|August 16, 2017
Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samplesRebecca M Davidson, Mary Ann DeGroote, Jamie L Marola, et al.
The Journal of Clinical Investigation|August 2, 2011
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionMaurizio Renna, Catherine Schaffner, Karen Brown, et al.
Pageof 1